issues with glp 1 Jennifer Manne-Goehler, MD, ScD, explains why GLP-1 medications shouldn't be used as a "quick fix" and outlines what to consider before taking them Exploring the Side Effects of

Do I need to diet and exercise as well

A large cardiovascular outcome trial in high-risk T2D patients treated with the GLP-1 analog liraglutide (LEADER) demonstrated impressive reductions in CV mortality (22%

But it ignored how that fat behaves inside the body

We recommend continuing GLP-1 RAs perioperatively in patients without significant gastrointestinal symptoms (significant symptoms include severe nausea, vomiting, and inability to tolerate oral intake and do not include fullness or early satiety) (B)

Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases